Annovis Bio, Inc.(ANVS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ANVS Annovis Bio, Inc.

盘前交易 08-21 05:05:34 EDT

1.79

-0.06

-3.24%

最高1.89	最低1.78	成交量54.88万
今开1.84	昨收1.85	日振幅5.95%
总市值7,615万	流通市值6,322万	总股本4,254万
成交额100.25万	换手率1.55%	流通股本3,532万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ANVS","market":"US","secType":"STK","nameCN":"Annovis Bio, Inc.","latestPrice":1.79,"timestamp":1787256000000,"preClose":1.85,"halted":0,"volume":548818,"delay":0,"changeRate":-0.03243243243243246,"floatShares":35319700,"shares":42541900,"eps":-1.789521,"marketStatus":"盘前交易","change":-0.06,"latestTime":"08-21 05:05:34 EDT","open":1.84,"high":1.89,"low":1.78,"amount":1002534.0179882001,"amplitude":0.059459,"askPrice":1.97,"askSize":100,"bidPrice":1.61,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.789521,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787319000000},"marketStatusCode":1,"adr":0,"listingDate":1580274000000,"exchange":"NYSE","adjPreClose":1.79,"postHourTrading":{"tag":"盘后","latestPrice":1.7838,"preClose":1.79,"latestTime":"19:42 EDT","volume":3555,"amount":6379,"timestamp":1787269330372,"change":-0.0062,"changeRate":-0.003464,"amplitude":0.03352},"volumeRatio":0.7794585326668918,"impliedVol":0.5616,"impliedVolPercentile":0.352},"requestUrl":"/m/hq/s/ANVS","defaultTab":"news","newsList":[{"id":"1142311152","title":"Annovis Bio 症状改善数据预计于2027年第一季度读出，疾病修饰数据预计于2028年第一季度读出","url":"https://stock-news.laohu8.com/highlight/detail?id=1142311152","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1142311152?lang=zh_cn&edition=full","pubTime":"2026-07-07 19:05","pubTimestamp":1783422329,"startTime":"0","endTime":"0","summary":"Annovis Bio Inc. 的关键临床试验数据读出时间表已获明确。针对症状改善效果的数据，预计将在2027年第一季度揭晓。而更为重要的、旨在评估药物能否改变疾病进程的数据，则计划于2028年第一季度公布。这一时间线为关注该公司的投资者提供了清晰的研究进展里程碑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANVS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189209653","title":"Annovis Bio阿尔茨海默病早期疗法关键三期试验完成患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=1189209653","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189209653?lang=zh_cn&edition=full","pubTime":"2026-07-07 19:04","pubTimestamp":1783422285,"startTime":"0","endTime":"0","summary":"Annovis Bio, Inc. (ANVS) 宣布，其针对早期阿尔茨海默病的候选药物buntanetap，在一项关键性的三期临床试验中，已成功完成全部患者的招募工作。这一里程碑标志着该疗法的临床开发进程迈入了新的重要阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160222773","title":"Annovis Bio任命CEO Maria Maccecchini暂代CFO职务 直至确定接任人选","url":"https://stock-news.laohu8.com/highlight/detail?id=1160222773","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1160222773?lang=zh_cn&edition=full","pubTime":"2026-03-26 05:21","pubTimestamp":1774473676,"startTime":"0","endTime":"0","summary":"生物制药公司Annovis Bio Inc宣布，其首席执行官Maria Maccecchini将暂时兼任首席财务官一职，直至公司寻得正式接任者。这一人事安排已通过美国证券交易委员会备案文件正式披露。Maria Maccecchini作为公司创始人兼首席执行官，对Annovis Bio的战略规划与运营体系具有深度把控，其暂代CFO职务将有效统筹财务战略与研发进度的协同推进。目前，Annovis Bio正专注于阿尔茨海默病及帕金森病等神经退行性疾病治疗药物的临床开发。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANVS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196592943","title":"Neurorpm将运用AI赋能数字生物标志物监测技术，助力Annovis Bio帕金森病临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1196592943","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1196592943?lang=zh_cn&edition=full","pubTime":"2026-03-19 19:33","pubTimestamp":1773920039,"startTime":"0","endTime":"0","summary":"Neurorpm宣布，将在Annovis Bio公司针对帕金森病开展的临床试验中部署其人工智能驱动的数字生物标志物监测方案。这一合作旨在通过先进技术提升试验数据的精确性与效率。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANVS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166468577","title":"Annovis Bio公司预估：现有现金及等价物可支撑运营至2026年第三季度","url":"https://stock-news.laohu8.com/highlight/detail?id=1166468577","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1166468577?lang=zh_cn&edition=full","pubTime":"2026-03-16 19:33","pubTimestamp":1773660792,"startTime":"0","endTime":"0","summary":"Annovis Bio公司宣布，根据最新财务评估，其持有的现金及现金等价物预计足以维持公司正常运营至2026年第三季度。这一资金储备将为公司核心研发项目的持续推进提供有力保障。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANVS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518797452","title":"Annovis Bio, Inc.盘中异动 早盘股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518797452","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518797452?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:12","pubTimestamp":1741619549,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时12分，Annovis Bio, Inc.股票出现异动，股价大幅跳水5.17%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Protagonist Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Aeon Biopharma, Inc.、Scisparc Ltd.较为活跃，换手率分别为3572.82%、955.62%、797.28%，振幅较大的相关个股有Scisparc Ltd.、Aeon Biopharma, Inc.、Dogwood Therapeutics, Inc.，振幅分别为49.87%、41.96%、41.36%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310231229abf32185&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310231229abf32185&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517916971","title":"Annovis Bio, Inc.盘中异动 下午盘快速下挫5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517916971","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517916971?lang=zh_cn&edition=full","pubTime":"2025-03-07 02:47","pubTimestamp":1741286878,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日02时47分，Annovis Bio, Inc.股票出现波动，股价急速跳水5.33%。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.86%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307024758963c7a56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307024758963c7a56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANVS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516654300","title":"Annovis Bio, Inc.盘中异动 股价大跌5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516654300","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516654300?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:13","pubTimestamp":1741025581,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时13分，Annovis Bio, Inc.股票出现异动，股价大幅跳水5.46%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304021301abe67433&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304021301abe67433&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANVS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514633891","title":"Annovis Bio, Inc.盘中异动 股价大涨5.17%报1.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514633891","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514633891?lang=zh_cn&edition=full","pubTime":"2025-02-28 01:04","pubTimestamp":1740675841,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日01时04分，Annovis Bio, Inc.股票出现波动，股价大幅拉升5.17%。截至发稿，该股报1.83美元/股，成交量25.9938万股，换手率1.33%，振幅4.89%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280104019632cf9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280104019632cf9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANVS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514184270","title":"Annovis Bio, Inc.盘中异动 早盘快速跳水5.33%报1.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514184270","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514184270?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:44","pubTimestamp":1740494663,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时44分，Annovis Bio, Inc.股票出现波动，股价快速下挫5.33%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224424a2538a38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224424a2538a38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANVS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514737897","title":"Annovis Bio, Inc.盘中异动 大幅下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514737897","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514737897?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:48","pubTimestamp":1740412113,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时48分，Annovis Bio, Inc.股票出现异动，股价大幅下挫5.00%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224234834abdb2022&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224234834abdb2022&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513213728","title":"Annovis Bio, Inc.盘中异动 股价大跌5.05%报2.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513213728","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513213728?lang=zh_cn&edition=full","pubTime":"2025-02-22 01:59","pubTimestamp":1740160745,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日01时59分，Annovis Bio, Inc.股票出现波动，股价快速下跌5.05%。截至发稿，该股报2.12美元/股，成交量21.8575万股，换手率1.12%，振幅6.44%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222015905962ba9b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222015905962ba9b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANVS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512488293","title":"Annovis Bio, Inc.盘中异动 股价大跌6.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512488293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512488293?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:33","pubTimestamp":1739975584,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时33分，Annovis Bio, Inc.股票出现异动，股价快速跳水6.45%。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223305a24bf9ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223305a24bf9ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANVS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511690164","title":"Annovis Bio, Inc.盘中异动 临近午盘急速上涨5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511690164","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511690164?lang=zh_cn&edition=full","pubTime":"2025-02-15 01:00","pubTimestamp":1739552451,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日01时00分，Annovis Bio, Inc.股票出现波动，股价急速拉升5.38%。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215010051abcf26ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215010051abcf26ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510076336","title":"Annovis Bio, Inc.盘中异动 快速下挫5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510076336","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510076336?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:51","pubTimestamp":1739289067,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时51分，Annovis Bio, Inc.股票出现异动，股价急速下跌5.11%。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为1.82%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211235108961f56d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211235108961f56d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANVS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510863949","title":"Annovis Bio, Inc.盘中异动 早盘股价大跌5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510863949","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510863949?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:33","pubTimestamp":1739198026,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时33分，Annovis Bio, Inc.股票出现异动，股价快速下挫5.44%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021022334698807879&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021022334698807879&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANVS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509253147","title":"Annovis Bio, Inc.盘中异动 早盘快速下挫5.03%报2.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509253147","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509253147?lang=zh_cn&edition=full","pubTime":"2025-02-08 00:15","pubTimestamp":1738944946,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日00时15分，Annovis Bio, Inc.股票出现异动，股价急速下跌5.03%。截至发稿，该股报2.93美元/股，成交量29.7182万股，换手率1.53%，振幅5.84%。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208001547a23d3aad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208001547a23d3aad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANVS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509946123","title":"Annovis Bio, Inc.盘中异动 急速下挫5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509946123","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509946123?lang=zh_cn&edition=full","pubTime":"2025-02-05 00:42","pubTimestamp":1738687361,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日00时42分，Annovis Bio, Inc.股票出现波动，股价大幅下挫5.40%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.63%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205004242987a5f68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205004242987a5f68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANVS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508149356","title":"Annovis Bio, Inc.股价重挫12.46% 市值跌732.87万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508149356","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508149356?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:35","pubTimestamp":1738593352,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时35分，Annovis Bio, Inc.股票出现波动，股价大幅下跌12.46%。截至发稿，该股报4.26美元/股，成交量15.2748万股，换手率1.11%，振幅8.73%。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.36%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223552abc1082b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223552abc1082b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANVS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505403360","title":"Annovis Bio, Inc.盘中异动 大幅跳水5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505403360","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505403360?lang=zh_cn&edition=full","pubTime":"2025-01-24 03:18","pubTimestamp":1737659904,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日03时18分，Annovis Bio, Inc.股票出现异动，股价急速跳水5.37%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.12%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124031824960e790f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124031824960e790f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANVS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.annovisbio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0.0229},{"period":"3month","weight":-0.1973},{"period":"6month","weight":-0.2782},{"period":"1year","weight":-0.2811},{"period":"ytd","weight":-0.4827}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0191},{"period":"3month","weight":0.0227},{"period":"6month","weight":0.1061},{"period":"1year","weight":0.1951},{"period":"ytd","weight":0.1183}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Annovis Bio, Inc.于2008年4月29日根据特拉华州法律注册成立。Annovis是一家临床阶段制药公司，专注于开发和商业化用于治疗帕金森氏症（“PD”）和阿尔茨海默氏症（“AD”）疾病以及神经退行性疾病的创新药物。该公司的先导化合物ANVS-401是一种神经化学神经缺陷疗法，可抑制神经变性并抑制神经毒性蛋白质转化为成人和正常化的轴突囊泡转运。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.040659},{"month":2,"riseRate":0.285714,"avgChangeRate":0.058949},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.056117},{"month":4,"riseRate":0.142857,"avgChangeRate":-0.132244},{"month":5,"riseRate":0.571429,"avgChangeRate":0.255652},{"month":6,"riseRate":0.428571,"avgChangeRate":0.139284},{"month":7,"riseRate":0.571429,"avgChangeRate":0.075716},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.057041},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.058484},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.073043},{"month":11,"riseRate":0.666667,"avgChangeRate":0.26823},{"month":12,"riseRate":0.333333,"avgChangeRate":0.124011}],"exchange":"NYSE","name":"Annovis Bio, Inc.","nameEN":"Annovis Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Annovis Bio, Inc.(ANVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Annovis Bio, Inc.(ANVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Annovis Bio, Inc.,ANVS,Annovis Bio, Inc.股票,Annovis Bio, Inc.股票老虎,Annovis Bio, Inc.股票老虎国际,Annovis Bio, Inc.行情,Annovis Bio, Inc.股票行情,Annovis Bio, Inc.股价,Annovis Bio, Inc.股市,Annovis Bio, Inc.股票价格,Annovis Bio, Inc.股票交易,Annovis Bio, Inc.股票购买,Annovis Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Annovis Bio, Inc.(ANVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Annovis Bio, Inc.(ANVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}